Is 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone? Is 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone safe for nursing mother and child? Does 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone extracts into breast milk? Does 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone has any long term or short term side effects on infants? Can 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone influence milk supply or can 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone decrease milk supply in lactating mothers?
4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone lactation summary
- DrLact safety Score for 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone usage in lactation
On latest update relevant data on breastfeeding was not found. Similar to Sumitriptan composition which is known to have a low excretion into breast milk.
Answer by DrLact: About 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone usage in lactation
No published experience exists with 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone during breastfeeding. If 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone is required by the mother, it is not a reason to discontinue breastfeeding; however, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Alternate Drugs
Vortioxetine(Low Risk)
Eletriptan(Safe)
Frovatriptan(Low Risk)
Zolmitriptan(Low Risk)
Almotriptan(Low Risk)
Rizatriptan(Low Risk)
Sumatriptan(Safe)
Naratriptan(Low Risk)
Sumatriptan(Safe)
Naratriptan(Low Risk)
Eletriptan(Safe)
Frovatriptan(Low Risk)
Cisapride(Safe)
Zolmitriptan(Low Risk)
Almotriptan(Low Risk)
Rizatriptan(Low Risk)
Eletriptan(Safe)
Frovatriptan(Low Risk)
Almotriptan(Low Risk)
Zolmitriptan(Low Risk)
Rizatriptan(Low Risk)
Sumatriptan(Safe)
Naratriptan(Low Risk)
Naratriptan(Low Risk)
Norepinephrine(Safe)
Epinephrine(Safe)
Eletriptan(Safe)
Frovatriptan(Low Risk)
Cocaine(Dangerous)
Pseudoephedrine(Low Risk)
Zolmitriptan(Low Risk)
Almotriptan(Low Risk)
Phenylephrine(Low Risk)
Rizatriptan(Low Risk)
Ergotamine(Unsafe)
Sumatriptan(Safe)